cannabidiol (GWP42003-P)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for cannabidiol (GWP42003-P), covering 2019-08-01 to 2022-02-03. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes [Phase 3]